 JHU ALLIANCE
The Johns Hopkins Alliance for Science & Technology Development is a 28-member committee charged with evaluating the commercial viability of selected research projects at Johns Hopkins University School of Medicine. The JHU Alliance will then evaluate marketing opportunities and provide assistance with the identification of financing to enable the commercialization of the worthy discoveries. The JHU Alliance consists of pharmaceutical and biotech executives, medical device designers and manufacturers, representatives from the diagnostics world, and venture capitalists, as well as angel investors. The JHU Alliance's charter is to evaluate research projects within the School of Medicine and determine the commercial strength of each project and assign a JHU Alliance member to champion its development and marketability. The group will also become the university's conduit toward creating awareness among industry leaders and business entrepreneurs. This alliance among business leaders and university researchers has been made possible under the provisions of the Bayh-Dole Act, which encourages the utilization of inventions produced under federal funding and promotes the participation of universities and small businesses in the development and commercialization process. It also permits exclusive licensing with transfer of an invention to the marketplace. For more information please contact: Helen Montag Corporate Relations Manager hmontag@jhmi.edu 410-516-4976 or 410-371-8776 The Johns Hopkins University Alliance for Science and Technology Development Industry Membership (“Alliance”) Aris Melissaratos, Chairman Senior Advisor to the President for Enterprise Development Johns Hopkins University Liza Bailey Private Investor/Retired Credit Suisse Investment Banking Manager Director James J. Barry, PhD VP Corporate Research & Advanced Technology Development --Boston Scientific David S. Block, MD, MBA Founder and CEO --Ruxton Pharmaceuticals, Inc. David S. Bredt, MD, PhD Vice President, Integrative Biology --Lilly Research Laboratories James Campbell, MD Scientific Advisor --Interwest Partners C. Thomas Caskey, MD, FACP Director & CEO --Brown Foundation Institute of Molecular Medicine Executive Vice President of Molecular Medicine and Genetics --The University of Texas Health Science Center at Houston Mr. Joseph A. Ciffolillo (retired medical device executive) Kenneth Fasman, PhD Vice President and Chief Technology Officer --Dr. Miriam and Sheldon G. Adelson Medical Research Foundation Robert Garland, MD Partner --New Enterprise Associates Philip Goelet, PhD Director --Red Abbey Ms. Elizabeth Good Director, Strategic Investments --University of Maryland at Baltimore Mr. Steve Gorlin Principal --Gorlin Companies Mr. David W. Hockenbrocht, Chairman Founding Chairman of the Alliance (Retired President & CEO of Sparton Corporation) Leroy E. Hood, MD, PhD President --Institute for Systems Biology Mr. Edwin M. Kania, Jr. Managing Partner and Chairman --Flagship Ventures Mr. Robert S. King FIVE PRIME ADVISORS, LLC Chris Kroeger, MD, MBA Principal --Aurora Funds, Inc. Joseph Lawler, MD, PhD Oz-Ziff Capital Management Group Robert D. Mashal, MD President & CEO --Alinea Pharmaceuticals Mr. Troy Moore Chief Technology Officer --Open Biosystems Mr. Richard Newman Vice President, Advanced Solutions, Emeritus --Welch Allyn, Inc. James Niedel, MD, PhD Managing Director --New Leaf Venture Partners, LLC Stephen N. Oesterle, MD Sr. Vice President for Medicine and Technology --Medtronic, Inc. John Perchorowicz, PhD Vice President, Business Development --RCT BioVentures/Research Corporation Technologies, Inc. James A. Poulos, III Vice President, Technology Transfer and Commercialization --Maryland Technology Development Corp. (TEDCO) Major General Garrison Rapmund, MD, U.S. Army, Retired Sr. Fellow, Krasnow Institute for Advanced Study, George Mason University Bruce C. Robertson, PhD Managing Director --H.I.G. Ventures Mark C. Rogers, MD, MBA Chairman and CEO --Bradmer Pharmaceuticals Christopher Shen, MD, MBA Partner --Essex Woodlands Health Ventures Irving Sherman, MD (retired neurosurgeon) Ms. Amita Shukla Principal --NEA Craig R. Smith, MD Williston Consulting, LLC (retired Chairman, President, & CEO, Guilford Pharmaceuticals) Joseph M. Smith, MD, PhD, FACC (formerly with Guidant Corporation) Guidant Corporation Jason Sydow, PhD Principal --Questmark Partners 
|